InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Cravatt Benjamin, Director. Officer active across 1 companies, notably FIBROGEN INC. Cumulatively, 3 disclosures have been published. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
015,777 shares0
Common Stock
SEC:0001209191-22-038606:0·
04,700 shares0
Common Stock
SEC:0001209191-21-036671·
04,700 shares0
Common Stock
SEC:0001209191-21-036671:0·
3 of 3 declarations
About Cravatt Benjamin
Benjamin Cravatt is a Board Member at FibroGen Inc. He brings expertise in biotechnology and corporate governance. In his role, Cravatt is involved in making strategic decisions that influence the company's direction.
